Perceived risk of gastric cancer associated with long-term use of proton pump inhibitors: Bridging the gap

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

410

Tables (1-2)

Sum=495

Publishing Process of This Article

Item

Count

Browse

Download

Sum=34

Jul 24, 2025 (publication date) through Aug 6, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Oncol. Jul 24, 2025; 16(7): 107091
Published online Jul 24, 2025. doi: 10.5306/wjco.v16.i7.107091

Table 2 Responses of gastroenterologists vs non-gastroenterologists

Characteristic	Gastro (n = 15)	Non-gastro (n = 18)	P value	Together (n = 33)
Have prescribed long-term PPI	15 (100)	14 (74)	0.0400^a	29 (87)
Aware of gastric cancer risk	15 (100)	7 (38)	0.0001^b	22 (66)
Will prescribe long-term PPI	14 (93)	12 (66)	0.0800	25 (75)

^aP < 0.05.

^bP < 0.01.

PPI: Proton pump inhibitors; Gastro: Gastroenterologist; Non-gastro: Non-gastroenterologist.

Citation: Sawaied IO, Samson AO, Golan E. Perceived risk of gastric cancer associated with long-term use of proton pump inhibitors: Bridging the gap. World J Clin Oncol 2025; 16(7): 107091
URL: https://www.wjgnet.com/2218-4333/full/v16/i7/107091.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i7.107091